November 20th Newsletter
FDA Issues Emergency Use Authorization for First At-Home COVID-19 Test On November 17th, the Food and Drug Administration (FDA) authorized the first prescription at-home COVID-19 test. The test, which was developed by Lucira Health, uses molecular amplification technology for the detection of SARS-CoV-2 RNA in patients with known or suspected COVID-19. It can be used…
Continue reading